+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Human Vaccine Market 2021-2025- Product Image
Global Human Vaccine Market 2021-2025- Product Image

Global Human Vaccine Market 2021-2025

  • ID: 5304713
  • Report
  • March 2021
  • Region: Global
  • 120 pages
  • TechNavio

FEATURED COMPANIES

  • Bavarian Nordic AS
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Pfizer Inc.
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Human Vaccine Market 2021-2025

The publisher has been monitoring the human vaccine market and it is poised to grow by $ 18.52 bn during 2021-2025 progressing at a CAGR of 7% during the forecast period. The report on human vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in investments in vaccines segment, need for novel vaccines for chronic infections, and public immunization programs funded by governments. In addition, increase in investments in vaccines segment is anticipated to boost the growth of the market as well.

The human vaccine market analysis includes RoA segment and geographical landscpes.

The human vaccine market is segmented as below:

By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW
By RoA
  • Intramuscular
  • Subcutaneous
  • Oral
  • Others
This study identifies the varied demand for vaccines in high-income and developing countries as one of the prime reasons driving the human vaccine market growth during the next few years. Also, R&D of novel vaccines, and advancement in vaccine delivery system will lead to sizable demand in the market.

The report on human vaccine market covers the following areas:
  • Human vaccine market sizing
  • Human vaccine market forecast
  • Human vaccine market industry analysis
The publisher robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human vaccine market vendors that include Bavarian Nordic AS, CSL Ltd., Daiichi Sankyo Co. Ltd., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Merck & Co. Inc., Mitsubishi Tanabe Pharma Corp., Pfizer Inc., Sanofi SA, and Serum Institute of India Pvt. Ltd.. Also, the human vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bavarian Nordic AS
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Pfizer Inc.
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by ROA
  • Market segments
  • Comparison by ROA
  • Intramuscular - Market size and forecast 2020-2025
  • Subcutaneous - Market size and forecast 2020-2025
  • Oral - Market size and forecast 2020-2025
  • Others - Market size and forecast 2020-2025
  • Market opportunity by ROA
Segmentation by Type
  • Segmentation by Type
Customer landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Bavarian Nordic AS
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd.
  • GlaxoSmithKline Plc
  • Inovio Pharmaceuticals Inc.
  • Merck & Co. Inc.
  • Mitsubishi Tanabe Pharma Corp.
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ billion)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Other1 - Market share 2020-2025 (%)
  • Comparison by Other1
  • Intramuscular - Market size and forecast 2020-2025 ($ billion)
  • Intramuscular - Year-over-year growth 2020-2025 (%)
  • Subcutaneous - Market size and forecast 2020-2025 ($ billion)
  • Subcutaneous - Year-over-year growth 2020-2025 (%)
  • Oral - Market size and forecast 2020-2025 ($ billion)
  • Oral - Year-over-year growth 2020-2025 (%)
  • Others - Market size and forecast 2020-2025 ($ billion)
  • Others - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Other1
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ billion)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ billion)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ billion)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ billion)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ billion)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Bavarian Nordic AS - Overview
  • Bavarian Nordic AS - Business segments
  • Bavarian Nordic AS - Key offerings
  • Bavarian Nordic AS - Key customers
  • Bavarian Nordic AS - Segment focus
  • CSL Ltd. - Overview
  • CSL Ltd. - Business segments
  • CSL Ltd. - Key offerings
  • CSL Ltd. - Key customers
  • CSL Ltd. - Segment focus
  • Daiichi Sankyo Co. Ltd. - Overview
  • Daiichi Sankyo Co. Ltd. - Business segments
  • Daiichi Sankyo Co. Ltd. - Key offerings
  • Daiichi Sankyo Co. Ltd. - Key customers
  • Daiichi Sankyo Co. Ltd. - Segment focus
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Key customers
  • GlaxoSmithKline Plc - Segment focus
  • Inovio Pharmaceuticals Inc. - Overview
  • Inovio Pharmaceuticals Inc. - Product and service
  • Inovio Pharmaceuticals Inc. - Key offerings
  • Inovio Pharmaceuticals Inc. - Key customers
  • Inovio Pharmaceuticals Inc. - Segment focus
  • Merck & Co. Inc. - Overview
  • Merck & Co. Inc. - Business segments
  • Merck & Co. Inc. - Key offerings
  • Merck & Co. Inc. - Key customers
  • Merck & Co. Inc. - Segment focus
  • Mitsubishi Tanabe Pharma Corp. - Overview
  • Mitsubishi Tanabe Pharma Corp. - Business segments
  • Mitsubishi Tanabe Pharma Corp. - Key offerings
  • Mitsubishi Tanabe Pharma Corp. - Key customers
  • Mitsubishi Tanabe Pharma Corp. - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key offerings
  • Sanofi SA - Key customers
  • Sanofi SA - Segment focus
  • Serum Institute of India Pvt. Ltd. - Overview
  • Serum Institute of India Pvt. Ltd. - Product and service
  • Serum Institute of India Pvt. Ltd. - Key offerings
  • Serum Institute of India Pvt. Ltd. - Key customers
  • Serum Institute of India Pvt. Ltd. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bavarian Nordic AS
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Pfizer Inc.
  • MORE
The publisher recognizes the following companies as the key players in the human vaccine market: Bavarian Nordic AS, CSL Ltd., Daiichi Sankyo Co. Ltd., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Merck & Co. Inc., Mitsubishi Tanabe Pharma Corp., Pfizer Inc., Sanofi SA, and Serum Institute of India Pvt. Ltd.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is varied demand for vaccines in high-income and developing countries.'

According to the report, one of the major drivers for this market is the increase in investments in vaccines segment.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Bavarian Nordic AS
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd.
  • GlaxoSmithKline Plc
  • Inovio Pharmaceuticals Inc.
  • Merck & Co. Inc.
  • Mitsubishi Tanabe Pharma Corp.
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll